International Journal of

Oncology ResearchISSN: 2643-4563

Current Issue

 Open Access DOI:10.23937/ijor-2017/1710011

Effect of Specific Music on Psychoneuroimmunological Responses

Abdul Waheed, David Kossor, William Collins and Amy Camie

Article Type: ORIGINAL ARTICLE | First Published: December 31, 2018

A pilot study was done to measure quantitative EEG (qEEG) brainwave frequencies and behavioral indices of five women undergoing chemotherapy treatment for cancer, before and after listening to specific music (The Magic Mirror-Inspired Reflections solo harp CD written, performed and recorded by Amy Camie) once a day for ten days. Following treatments, the EEG profile for all five participants improved and subjective reports from daily questionnaires confirmed a positive effect of the music....

 Open Access DOI:10.23937/ijor-2017/1710010

Absorbed Radiation Dose in the Thyroid Gland Following Regional Nodal Irradiation for Breast Cancer

Tahani Nageeti, Mohamed Mahfouz, Mazen Al Gaod and Reem Zatar

Article Type: Original Article | First Published: November 19, 2018

Radiation exposure to the thyroid gland is unavoidable in breast cancer (BC) radiotherapy (RT). This study was conducted to evaluate the impact of using different supraclavicular (SCV) field angles on the percentage volume of the dose absorbed by the thyroid relative to the maximum dose absorbed by the spinal cord. A total of 50 consecutive BC patients undergoing planning computed tomography (CT) were evaluated. The thyroid gland, spinal cord, and SCV nodal volumes were contoured on the planning...

 Open Access DOI:10.23937/ijor-2017/1710009

Pembrolizumab Monotherapy in Relapsed Hepatocellular Carcinoma Post Living Donor Liver Transplantation and Sorafenib

Fadi Nasr, Ahmad Al Ghoche, Saada Diab, Janah Maddah, Layal Mansour, Ali kassem and Abd El Karim Gheith

Article Type: Case Report | First Published: November 12, 2018

Despite of the high incidence of hepatocellular carcinoma (HCC), treatment strategies stays restrained. New treatment aspects remain a necessity to improve overall survival of patients. Here, we report for the first time a 2 years complete remission of hepatocellular carcinoma with pembrolizumab after failure of sorafenib and progression after liver transplantation. Immunotherapy became a field of interest in HCC for researchers and clinicians in order to establish new immunotherapy modalities t...

 Open Access DOI:10.23937/IJOR-2017/1710008

Organoids as Reliable Breast Cancer Study Models: An Update

Andrew Octavian Sasmita and Ying Pei Wong

Article Type: Review Article | First Published: October 06, 2018

Having been identified for centuries, breast cancer still remains one of the leading causes of death in women. Within the United States of America (USA) alone, it is estimated that over 60,000 women would have developed new cases of malignant breast cancer in 2017 alone; thus, calling an attention for the development of a reliable and effective breast cancer model for drug discovery to combat the disease or diagnostics to predict the progression of the disease. Current breast cancer models invol...

 Open Access DOI:10.23937/IJOR-2017/1710007

Economic Costs of Lung Cancer in China

Shaoyu Fan, Zhengzhong Mao, Anita H Lee and Teh-wei Hu

Article Type: Case Report | First Published: September 29, 2018

The estimated total national medical cost of treating lung cancer patients in China was 64.21 billion RMB (US$ 10.31 billion), about 2% of total medical costs in 2015. Total lung cancer costs in 2015 were 488.53 billion RMB (US$ 78.42 billion), about 75% of which can be attributed to mortality costs. Two-thirds of the lung cancer patients in the sample were either current or former smokers. The major economic costs of lung cancer among smokers are preventable. China has a relatively low cigarett...

 Open Access DOI:10.23937/ijor-2017/1710006

Clinico‚Äźpathological Features and Outcome of Treatment of Saudi Patients with Oral Cavity Cancer: A Single Institutional Experience

Ashraf Farrag, Arif Shaukat, Muhammad Ali and Magdy Kandil

Article Type: Research Article | First Published: July 28, 2018

Oral cancer is the most common head and neck cancer (HNC). Its global incidence in 2015 was 410,000 cases with 146,000 deaths. In USA, 41,380 patients were diagnosed with HNC in 2013, and oral cavity cancers accounted for almost 30,000 of new cases. In Saudi Arabia, a total number of 211 oral cancer cases were reported in 2014, representing about 1.8% of the total cancer cases....

Volume 1
Issue 2